Xavo, a leading provider of Software-as-a-Service for Biopharma R&D with offices in Boston, MA, Bayreuth, Germany and Basel, Switzerland, announced today that it will participate in the SLAS Europe 2022 Dublin event from May 24th – 27th, 2022. In the exhibition space of the conference, Xavo can be found at Booth C010 where its transformative approach to Sample Management Software will be presented.
As part of Xavo’s mission to accelerate the Biopharma R&D value chain, Xavo is continuously enabling Sample Management in Biopharma R&D by addressing the strategic problem of optimally fulfilling demand in the form of material requests based on available finite lab capacity and material inventory. Xavo R3 helps Sample Management groups to consistently deliver the right material in the right format to the right recipient in the right quality to promise on time every time by providing the best combination of functional and non-functional means.
“As a Corporate Member of SLAS, we are excited to participate in the SLAS Europe 2022 Dublin event. It’s great to reconnect with our European customers for the first time in person after the pandemic”, says Ralf Sonnefeld, Executive Vice President Marketing & Sales of Xavo. He continues: “We have used the last 2 years to rethink our approach to the Biopharma R&D market and how we can best support scientific services that provide material and assay results to scientists. And we can’t wait to show to the European SLAS community what we’ve come up with.”
At this year’s SLAS Europe event, Xavo is using the theme of ‘Sample Management Software – reimagined’ to emphasize that it has developed new ways to address latest trends and challenges in the Sample Management realm. Xavo has reimagined how Sample Management Software should be to help scientific services to get their important job done optimally by providing the best combination of functional and non-functional means through its Software-as-a-Service, ‘Xavo R3’